Vistagen Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2000 | — | $-844.1K | — |
| FY2001 | — | $-2.5M | — |
| FY2002 | — | $-4.6M | — |
| FY2003 | — | $-4.9M | — |
| FY2004 | — | $-13.7M | — |
| FY2005 | — | $-14.7M | — |
| FY2006 | — | $-16.5M | — |
| FY2007 | — | $-17.4M | — |
| FY2008 | — | $-22.2M | — |
| FY2009 | — | $-26.7M | — |
| FY2010 | — | $-26.3M | $201.0K |
| FY2011 | — | $-32.9M | $139.3K |
| FY2012 | — | $-5.7M | $81.0K |
| FY2013 | — | $-12.6M | $638.1K |
| FY2014 | $2.1M | $-12.8M | — |
| FY2015 | $1.5M | $-20.5M | $70.0K |
| FY2016 | $58.8K | $-3.0M | $428.5K |
| FY2017 | — | $615.8K | $2.9M |
| FY2018 | — | $6.9M | $10.4M |
| FY2019 | — | $7.1M | $13.1M |
| FY2020 | — | $-5.7M | $1.4M |
| FY2021 | — | $92.0M | $103.1M |
| FY2022 | — | $64.7M | $68.1M |
| FY2023 | — | $12.1M | $16.6M |
| FY2024 | — | $114.3M | $119.2M |
| FY2025 | — | $70.4M | $67.1M |
| FY2026 | — | $35.5M | $30.8M |